Projections of glutamatergic somatosensory and auditory fibers to the cochlear nucleus (CN) are mostly nonoverlapping: projections from the spinal trigeminal nucleus (Sp5) terminate primarily in the granule cell domains (GCD) of CN, whereas type I auditory nerve fibers (ANFs) project to the magnocellular areas of the VCN (VCNm) and deep layers of Dorsal CN (DCN). Vesicular glutamate transporters (VGLUTs), which selectively package glutamate into synaptic vesicles, have different isoforms associated with distinct subtypes of excitatory glutamatergic neurons. Here we examined the distributions of VGLUT1 and VGLU2 expression in the CN and their colocalization with Sp5 and ANF terminals following injections of anterograde tracers into Sp5 and the cochlea in the guinea pig. The CN regions that showed the most intense expression of VGLUT1 and VGLUT2 were largely nonoverlapping and were consistent with ANF and Sp5 projections, respectively: VGLUT1 was highly expressed in VCNm and the molecular layer of the DCN, whereas VGLUT2 was expressed predominantly in the GCD. Half (47% Ϯ 3%) of the Sp5 mossy fiber endings colabeled with VGLUT2, but few (2.5% Ϯ 1%) colabeled with VGLUT1. In contrast, ANFs colabeled predominantly with VGLUT1. The pathway-specific expression of VGLUT isoforms in the CN may be associated with the intrinsic synaptic properties that are unique to each sensory pathway. J. Comp. 
Projections from the trigeminal sensory complex to the cochlear nucleus (CN; Haenggeli et al., 2005; Zhou and Shore, 2004) are integrated with auditory inputs from the cochlea (Shore, 2005) . Synaptic terminals of fibers from the spinal trigeminal nuclei (Sp5) and trigeminal ganglion are mostly confined to the granule cell domain (GCD) of the CN. The GCD includes both the superficial shell region of the ventral CN (VCN) and the fusiform cell layer of dorsal cochlear nucleus (DCN) and contains numerous small cells, including granule cells (Weedman et al., 1996; Zhou and Shore, 2004) . The Sp5 projection gives rise to small boutons and large, irregular swellings (i.e., mossy fibers; MFs) that make contacts with granule cells (Haenggeli et al., 2005; Zhou and Shore, 2004) . Together with other somatosensory pathways to the CN, the Sp5 projection conveys proprioceptive information related to head/neck position and vocal tract gestures that are necessary for facilitating sound localization and attenuating body-generated sounds (Kanold and Young, 2001; Shore, 2005; Shore and Zhou, 2006) . Somatosensory projections to CN have also been linked to tinnitus by the observations that tinnitus patients can modulate their tinnitus with head and neck manipulations (Levine, 1999) .
Identification of neurotransmitters associated with trigeminal projections to CN is necessary for a better under-standing of multisensory integration in the CN. Earlier studies demonstrated that MFs in the CN originating in the cuneate nucleus contain round synaptic vesicles, make asymmetric synapses with postsynaptic targets, and are labeled with an antibody to glutamate, suggestive of a glutamatergic pathway (Wright and Ryugo, 1996) . MFs from other sources, such as the pontine nucleus, have similar ultrastructural characteristics (Ohlrogge et al., 2001; Weedman et al., 1996) . The evidence presented in this paper suggests that the Sp5 pathway to the CN is also glutamatergic.
Vesicular glutamate transporters (VGLUTs) selectively package glutamate into synaptic vesicles and mediate glutamate transport. VGLUTs therefore serve as excellent markers of glutamatergic neurons. Three subtypes, VGLUT1, VGLUT2, and VGLUT3, have been identified in the central nervous system. Although they are structurally homologous and accumulate glutamate with similar transport kinetics (Fremeau et al., 2002; Gras et al., 2002; Takamori et al., 2001) , their distributions in the brain are distinct. Both VGLUT1 and VGLUT2 are abundantly expressed in the brain and account for the majority of known glutamatergic neurons in the central nervous system, whereas VGLUT3 is restricted to small, often nonglutamatergic populations of neurons in the brain. Furthermore, VGLUT1 and VGLUT2 show mutually exclusive distributions in the adult mammalian brain: VGLUT1 is intensely expressed in the cerebral and cerebellar cortices and hippocampus, whereas VGLUT2 is expressed predominantly in the thalamus, deep cerebellar nuclei, and many brainstem regions (Fremeau et al., 2001; Herzog et al., 2001; Kaneko et al., 2002; Takamori et al., 2001) .
Both VGLUT1 and VGLUT2 (Herzog et al., 2004; Kaneko et al., 2002) , but not VGLUT3, are expressed in the CN in the adult rodent (Herzog et al., 2004) . The two VGLUT isoforms show little overlapping expression in the CN: VGLUT1 is more intense in the core region of VCN, whereas VGLUT2 expression is stronger in the shell regions of VCN (Kaneko et al., 2002) . Since the GCD is the major recipient of Sp5 and other somatosensory inputs (Haenggeli et al., 2005; Zhou and Shore, 2004) , this suggests the association of VGLUT2 with nonauditory inputs to the CN. In contrast, the core region of CN receives input from glutamatergic type I auditory nerve fibers (ANFs; Altschuler et al., 1984; Brown and Ledwith, 1990; Liberman, 1993; Martin, 1985; Schweitzer et al., 1991) . It is thus likely that type I ANFs use VGLUT1 to mediate the glutamate transport. In the present study, our primary goal was to identify whether glutamate is associated with trigeminal projections to CN. Concurrently, we examined the differential distributions of VGLUT2 and VGLUT1 expression in the CN and their association with the Sp5 and ANF projections to the CN. Differential association of VGLUT isotypes with Sp5 and ANF projections to the CN demonstrated in this study warrant further investigation of other nonauditory afferents to the CN.
MATERIALS AND METHODS

Animal preparation
The experiments were performed on 12 pigmented guinea pigs, weighing 300 -400 g. All procedures were performed in accordance with the NIH guidelines for the use and care of laboratory animals (NIH publication No. 80-23) and guidelines provided by the University Committee on Use and Care of Animals (UCUCA) of University of Michigan.
Four animals were used for studying VGLUT immunoreactivity (VGLUT-ir) in the CN. The animals were euthanized with Nembutal (15 mg/kg, i.p.) and transcardially perfused with 0.1 M phosphate-buffered saline (PBS), followed by 4% paraformaldehyde in PBS. After perfusionfixation, the brain was isolated and placed in the same fixative for 2 hours at 4°C. The brain was transferred into 30% sucrose in 0.1 M PBS overnight at 4°C, and the brainstem was then sectioned on a freezing microtome at a thickness of 40 m.
Eight guinea pigs were used in a double-labeling fluorescence study to identify the colocalization of VGLUT1-ir and VGLUT2-ir with the terminals of Sp5 fibers (n ϭ 6) and ANFs (n ϭ 2). These animals were anesthetized with intramuscular injections of ketamine hydrochloride (Ketaset; 40 mg/kg) and xylazine (Rompun; 10 mg/kg) and placed in a stereotaxic frame (David Kopf, Tujunga, CA). Rectal temperature was maintained at 38°C Ϯ 0.5°C with a thermostatically controlled heating pad. The surgical procedure for injections of anterograde tracers in the Sp5 has been described previously (Zhou and Shore, 2004) . A total volume of 0.1-0.3 l tracer [10% biotinylated dextran-amine (BDA); MW 10,000: Molecular Probes, Eugene, OR; or Fluoro-Ruby (FR): Molecular Probes] was sterotaxically pressure-injected into the Sp5 with a Hamilton microsyringe equipped with a glass micropipette (20 -30 m tip). Tracer injections into the cochlea [Fluoro-Gold (FG): Fluorochrome, LLC, Denver, CO] were achieved by making a small hole in the round window membrane, which was then plugged with a small, tracer-soaked piece of gelatin sponge (Shore and Moore, 1998) . Four to six days after the injections, animals were killed, and the brains were processed and sectioned as described above.
Tissue processing and immunocytochemistry
Sections were mounted in serial order on clean glass slides and air dried. Alternate serial sections were used to label VGLUT1 and VGLUT2. All tissue processing was at room temperature (20 -22°C) unless otherwise stated. Polyclonal antibodies were generated in rabbits against Strep-Tag fusion protein containing amino acid residues 456 -560 of rat VGLUT1 (Synaptic Systems; catalog (Hioki et al., 2003; Kaneko et al., 2002; Takamori et al., 2001) , so cerebellar cortex was used as the positive control. To visualize BDA-labeled Sp5 terminals colabeled with VGLUT-ir, sections were incubated for 2 hours with rhodamine red-X conjugated with streptavidin (S6366; Molecular Probes), followed by immunolabeling with VGLUTs.
Western blots
Brain tissue (cerebellum and CN) was collected and homogenized with a sonicator in an ice-cold lysis buffer (1% NP40 in PBS) with protease inhibitors (Roche Molecular Biochemicals, Indianapolis, IN). The homogenate was centrifuged for 5 minutes at 14,000 rpm, and total protein concentration was measured with the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA). Equal concentrations of protein (25 g per lane) were separated by SDS-PAGE and transferred to a nitrocellulose membrane. After blocking with PBS-Tween 20 containing 5% nonfat dry milk, immunoblotting with primary antibodies was performed (1: 3,000 for both anti-VGLUT1 and anti-VGLUT2); secondary antibodies (anti-rabbit-HRP from Sigma) were diluted at 1:10,000 in PBS-Tween 20 with 5% milk. Signals were then revealed with ECL (Amersham Pharmacia Biotech, Arlington Heights, IL) and exposed to Hyperfilm (Amersham Pharmacia Biotech). Western blot analysis of proteins from CN and cerebellum (CB) with anti-VGLUT1 and anti-VGLUT2 antibodies. Anti-VGLUT1 antibody recognized a single band at ϳ60 kDa, and anti-VGLUT2 antibody recognized a single band at ϳ65 kDa, corresponding to the molecular weights predicted for VGLUT1 and VGLUT2, respectively. Molecular weight standards are indicated at left (kDa). B: VGLUT1-ir and VGLUT2-ir in the cerebellar cortex, as the positive control (M, molecular layer; P, Purkinje cell layer; G, granular layer). C: VGLUT1-ir in the CN at low magnification (ϫ10). VGLUT1 is intensely expressed in DCN1 and VCNm; weak to moderate VGLUT1-ir is found in the shell and DCN2; weak VGLUT1-ir is seen in DCN3. D: VGLUT2-ir in the CN at low magnification (ϫ10). VGLUT2 is expressed predominantly in the shell; moderate VGLUT2-ir is found in DCN2; very weak to weak staining is found in DCN1, VCNm, and DCN3. Scale bars ϭ 50 m in B; 0.5 mm in C,D.
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Image processing and confocal laser microscopy
Sections were examined with a fluorescent microscope equipped with the appropriate filters for rhodamine and Alexa fluor 488 (Leica, DM). Photomicrographs of immunolabeling were digitized and imported to Metamorph for quantification of immunolabeling. The parameters for digitizing photomicrographs were determined in a pilot study with optimal contrast between labeling and background and were then kept constant across conditions and animals. Photomicrographs were imported into Adobe Photoshop for contrast adjustment.
Analysis of VGLUT-ir was conducted for all subdivisions of the CN, with emphasis on the following regions: the DCN molecular layer (DCN1), the fusiform cell layer (DCN2), the deep DCN (DCN3), the VCN magnocellular areas (VCNm), and the shell region of VCN. In the doublelabeling study, alternate serial sections were used to label VGLUT1 and VGLUT2, respectively. Under epifluorescence, the labeled Sp5 terminals were manually counted on alternate sections in each group. Double labeling of Sp5 terminals with VGLUT-ir was determined by frequently switching the filters and adjusting the focusing of the objective lens. Colocalization was established when the two different labels (VGLUT and Sp5) exactly marked the same profile at the same focusing level. The number of terminal counts was multiplied by 4 to achieve the total terminal counts and corrected for double-counting errors by using Abercrombie's correction: corrected number ϭ count ϫ [section thickness/(section thickness ϩ terminal size)] (Abercrombie, 1946) . The labeled Sp5 terminal endings were classified as: 1) MF-like terminal endings: large irregular swellings (Ն2 m), which usually give rise to collaterals; 2) small boutons: small and round or oval (Ͻ2 m), including en passant and terminal boutons (Zhou and Shore, 2004) .
In some cases, double-labeled immunofluorescent terminals were also identified by confocal laser microscopy (Zeiss LSM 510). The images immunolabeled with Alexa 488 and rhodamine were scanned with lasers of argon and HeNe1, respectively. The images immunolableled with FG were scanned with a UV laser with an excitation wavelength of 364 nm, filtered using an emission LP filter at 560 nm, and viewed on the red channel. Images were acquired at a 1-m optical thickness. To obtain a clear view of terminal profiles, a series of six to 11 serial optical sections was obtained to generate a Z-projection of stacks. The double-labeled ANF terminals were counted manually from photomicrographs of confocal images (ϫ63) of 1-m optical thickness. Two sections were selected from both the DCN3 and the VCNm. The labeled ANF terminal endings were classified as 1) endbulb-like terminals, a group of puncta aligned in a circle or semicircle around a large cell body, or 2) bead-like terminals, small and round or oval (Ͻ2 m), including en passant and terminal boutons. Puncta that were yellow on the confocal multichannel images indicated colocalization.
Quantification and statistical analysis
To quantify VGLUT-ir in the CN, three sections were selected from each of the following regions: the DCN, magnocellular VCN, and shell region. For each of these regions, sections spanned evenly from rostral to caudal (i.e., one section from the 25th percentile, one from the median, and one from the 75th percentile). For VCN and shell region, two pictures (ϫ40) were taken of each selected section. For DCN, layers 1, 2, and 3 were photographed separately, yielding a total of six photomicrographs (ϫ40) for each chosen DCN section. In addition, two pictures with higher magnification (ϫ63) were taken of DCN1 at each selected level for the purpose of manual counting (see below). Quantification for each region (DCN, VCN, and shell region) was based on three sections/ regions in each animal. The photomicrographs were then transferred to Metamorph for quantification. The number of puncta and the pixel intensity of VGLUT-ir were semiautomatically measured: To ensure that puncta were counted reliably, visual inspections and manual corrections were always conducted after each automated counting. Because of the high density of VGLUT1-ir in DCN1, VGLUT-labeled puncta (VGLUT1 and 2) were counted manually in a chosen area by using photomicrographs with higher magnification (ϫ63). The number of VGLUTlabeled puncta was divided by the chosen area to yield the puncta density.
For quantitative assessment of intensity of VGLUT expression, the overall pixel value of VGLUT-ir for each photomicrograph was first corrected by subtracting the overall pixel value for a negative control section (i.e., without primary antibodies). The corrected value was then divided by the chosen area of counting, yielding the intensity per unit area (i.e., density of VGLUT expression expressed as pixel value/mm 2 ). Pixel densities less than 1 ϫ 10 6 pixel value/mm 2 were defined as very weak, 1-2 ϫ 10 6 pixel value/mm 2 as weak, 2-4 ϫ 10 6 pixel value/mm 2 as moderate, and Ͼ4 ϫ 10 6 pixel value/mm 2 as intense. Means and SEMs were calculated for the following: 1) puncta density of VGLUT1-and VGLUT2-ir, 2) density of VGLUT expression, 3) number of Sp5-labeled terminals, 4) number of Sp5-labeled terminals colabeled with VGLUT1 and VGLUT2, and 5) percentage ratios of Sp5 terminals colabeled with VGLUT1 and VGLUT2. Student's paired t-test was used to perform comparisons between means.
RESULTS
VGLUT expression in the CN
Western blot analysis with anti-VGLUT1 antibody showed a single band at ϳ60 kDa on protein extracted from both CN and cerebellum (CB; Fig. 1A) , and anti-VGLUT2 antibody recognized a single band at ϳ65 kDa, corresponding to the molecular weights predicted for VGLUT1 and VGLUT2, respectively. Positive controls for VGLUT-ir in the cerebellar cortex revealed dense, granular VGLUT1-ir and sparse, beaded VGLUT2-ir in the molecular layer (M in Fig. 1B) , and coarse VGLUT1 and Fig. 1B) , as previously demonstrated (Kaneko et al., 2002; Nunzi et al., 2003) . The most intense VGLUT1-ir was in the molecular layer of DCN (Fig. 1C, DCN1 ) and magnocellular area of VCN (VCNm, Fig. 1C ). Weak to moderate VGLUT1-ir was observed in the shell region of VCN and DCN2. VGLUT1-ir in DCN3 was weak or very weak. In contrast, the most intense VGLUT2-ir was in the shell region (Fig.  1C) . VGLUT2-ir was moderate in DCN2 and weak or very weak in DCN1, DCN3, and VCNm (Fig. 1D) .
VGLUT2-ir in the granular layers (G in
VGLUT1 labeling was in the form of small granules, densely distributed in DCN1 ( Fig. 2A) and also scattered in other CN subdivisions ( Fig. 2A-E) . Large, irregular granules in DCN2 and shell region (Fig. 2C) or endbulblike structures around large somata in VCNm were also observed (Fig. 2D,E) . The small granules in DCN1 and the endbulb-like structures around large cell bodies in VCNm were the major types of VGLUT1-labeled endings in the CN. VGLUT2 labeling, on the other hand, was mainly in the form of large, irregular granules in DCN2 and shell region ( Fig. 2F -J) that were larger and more intense than VGLUT1-labeled granules in the same CN region (Fig.  2H ). Small to medium-sized VGLUT2-labeled granules were observed in the DCN2 and DCN3 (Fig. 2F,G) , shell region (Fig. 2H) , and VCNm (Fig. 2I,J) .
Quantification of VGLUT-ir in CN
VGLUT2-ir was significantly more intense than VGLUT1-ir in the shell region and DCN2 ( Fig. 3A; paired t-test, P Ͻ 0.01), whereas VGLUT1-ir was significantly more intense than VGLUT2-ir in the VCNm and DCN1 ( Fig. 3A; paired t-test, P Ͻ 0.001). Similarly, the puncta density of VGLUT2-labeled granules was significantly greater than that of VGLUT1-labeled granules in the shell region and DCN2 ( Fig. 3B ; paired t-test, P Ͻ 0.05), whereas the puncta density of VGLUT1-labeled granules was significantly greater than that of VGLUT2-labeled granules in the VCNm and DCN1 ( Fig. 3B ; paired t-test, P Ͻ 0.01).
Sp5 terminals colabel with VGLUT2
Six animals were injected with anterograde tracers in the ipsilateral Sp5 (Sp5I, pars interpolaris). Data analysis focused on two animals in which the injections were limited to Sp5I, without diffusion to adjacent areas. In the other four animals, some spread to the adjacent inferior cerebellar peduncle (icp) and the lateral medullar reticular formation occurred. We have previously demonstrated that the icp does not contribute to the Sp5-CN projection (Zhou and Shore, 2004) . Although the medullar reticular formation does project to the CN , the region that contains the most CN projection neurons is rostral to the Sp5I and Sp5C (pars caudalis). In the present study, all injections were located in the intermediate to caudal part of Sp5I. In addition, the distribution, morphology, and colocalization of the labeled terminal endings with VGLUT-ir from these four animals were similar to those from animals with restricted injections. Therefore, contributions from lateral medulla reticular formation to the terminal labeling in the CN were minimal. Nonetheless, the quantification analysis was based only on the two animals in which the injections were restricted to the Sp5.
Colocalization of Sp5 endings with VGLUT2. The most prominent Sp5 labeled terminals were large, irregular swellings (Ն2 m), characteristic of MFs (Weedman et al., 1996; Wright and Ryugo, 1996) , in the GCD (Figs.  4A-F, 6A ). Sp5 MFs that colabeled with VGLUT2 (47.7% Ϯ 3%, Figs. 4, 6C) were restricted to the GCD (Fig. 6B) , which receives the majority of Sp5 terminals (Zhou and Shore, 2004) . These endings did not show morphological or topographical differences from those that did not colabel with VGLUT2 ( Fig. 4D-F) . A lower percentage of the small Sp5 boutons (Ͻ2 m) located throughout the CN colabeled with VGLUT2 (11.5% Ϯ 0.5% in the GCD, and 12.1% Ϯ 8% in the VCN; Figs. 4G-L, 6B). No colocalization of Sp5 boutons with VGLUT2-ir was evident in DCN1 and DCN3 (Fig. 6B) .
Lack of colocalization of Sp5 endings with VGLUT1. In strong contrast, the majority of labeled Sp5 terminals, including MFs and small boutons, did not colocalize with VGLUT1-ir (Figs. 5, 6 ). Few Sp5 MFs (2.5% Ϯ 1%) colabeled with VGLUT1, significantly fewer than were colabeled with VGLUT2 (47.7% Ϯ 3%; paired t-test, P Ͻ 0.05). These VGLUT1-labeled Sp5 MFs did not show morphological or topographical differences from those that did not colabel with VGLUT1 or VGLUT2. No small Sp5 boutons colabeled with VGLUT1. The paucity of colocalization of Sp5 terminals with VGLUT1-ir was evident in all CN subdivisions, even in the DCN1 that showed intense VGLUT1 expression (Fig. 5C ). Only 2% Ϯ 0.1% of total Sp5 terminal endings (both MFs and small boutons) colabeled with VGLUT1, significantly fewer than colabeled with VGLUT2 (23.6% Ϯ1%; paired t-test, P Ͻ 0.05).
ANF terminals colabel with VGLUT1
Infusion of FG into the labyrinth resulted in heavy labeling of ANFs and their terminals in the VCNm and the DCN3, but only a few labeled axons entered the shell region. The most prominent ANF terminal endings in the CN were the endbulb-like endings in the VCNm (Fig. 7) . In addition, large numbers of bead-like terminal boutons were evident in the VCNm and the DCN3. Most labeled ANF endbulb-like terminals ( Fig. 6D ; 79.5% Ϯ 7%) colocalized with VGLUT1 in VCNm (Fig. 7A, arrows) . Many bead-like ANF terminals or small boutons were also labeled with VGLUT1 in VCNm (Fig. 7A, arrowheads; 43.0% Ϯ 3%; see also Fig. 6D ) and DCN3 (Fig. 7B , arrowheads; 26.0% Ϯ 5%; see also Fig. 6D ). These small ANF boutons that were colabeled with VGLUT1 were not morphologically or topographically different from those that were not colabeled with VGLUT1. In contrast, neither ANF endbulb-like terminals (0%; Fig. 6D ) nor small boutons (0%; Fig. 6D ) was colocalized with VGLUT2 ( Fig.  7C,D) . 
DISCUSSION
This work confirms previous findings that VGLUT expression in the CN is differentially distributed according to region (Herzog et al., 2001; Kaneko et al., 2002) . We extend these findings by demonstrating that the differential distributions of VGLUT1 and VGLUT2 are associated with different sources of afferent inputs to the CN: Sp5 projections were colocalized with VGLUT2, whereas VIIIth nerve projections to the CN were colocalized with VGLUT1.
VGLUT expression in the CN is associated with different sources of afferent input
The most intense VGLUT1-ir was seen in the VCNm and DCN1, whereas the most intense expression of VGLUT2 was in the GCD. These CN subdivisions are associated with different sources of afferent inputs: The GCD, encompassing the shell region and DCN2, receives projections from variety of nonauditory sources, including the Sp5, the trigeminal ganglion, reticular formation and the cuneate nucleus (Haenggeli et al., 2005; Li and Mizuno, 1997; Ohlrogge et al., 2001; Shore et al., 2000; Weedman et al., 1996; Wright and Ryugo, 1996; Zhou and Shore, 2004; Shore and Zhou, 2006) . The magnocellular regions of the CN, including both VCNm and DCN3, receive projections from type I ANFs (Brown and Ledwith, 1990; Fekete et al., 1984; Liberman, 1993; Shore and Moore, 1998) . The DCN1, the most superficial layer of DCN, comprises predominantly parallel fiber inputs from granule cells in the GCD. Thus, VGLUT1 and -2 may be specifically associated with the synaptic transmission of these different circuits.
The morphological appearances of VGLUT-ir puncta also suggest circuit-specific associations. VGLUT2-ir puncta in the GCD were mostly in the form of large, irregular swellings that resemble MFs. The sources of MF endings include several nonauditory structures, including somatosensory systems and the reticular formation (Haenggeli et al., 2005; Ohlrogge et al., 2001; Shore and Zhou, 2006; Weedman et al., 1996; Wright and Ryugo, 1996; Zhou and Shore, 2004) . As shown here, the Sp5 terminal endings in the CN are either small boutons or large Mfs, which is consistent with previous studies (Haenggeli et al., 2005; Ohlrogge et al., 2001; Wright and Ryugo, 1996; Zhou and Shore, 2004) .
In contrast, numerous endbulb-like VGLUT1 labeled terminals from type I ANFs were seen around large cell bodies in the VCNm, suggesting that the ANF glutamatergic projection to CN is mediated by VGLUT1. The intense, small granular labeling of VGLUT1 in the DCN1 indicates that VGLUT1 is associated with intrinsic connections within the CN, i.e., the parallel fiber-to-DCN projection. This is consistent with the findings that parallel fiber terminals in the cerebellar cortex use VGLUT1 for accumulation of glutamate into the synaptic vesicles (Fremeau et al., 2004a; Kaneko et al., 2002) .
VGLUT2 mediates glutamate transport at Sp5 terminals
The colocalization of VGLUT2-ir with Sp5 terminals demonstrated here indicates that 1) the Sp5 pathway to the CN is glutamatergic and 2) Sp5 projections to CN use VGLUT2 to mediate glutamate transport at both their MF-and small bouton terminal endings. MF terminals in the CN resemble those in the cerebellar cortex. They are located predominantly in the GCD and make synaptic connections with the dendric claws of granule cells (Weedman et al., 1996) . Sp5 small boutons, which are more numerous than Sp5 MFs, probably make contacts with cells other than granule cells (Haenggeli et al., 2005; Zhou and Shore, 2004) , as observed for bouton terminals from other nonauditory projections to the CN, including those from the cuneate and pontine nuclei (Ohlrogge et al., 2001; Wright and Ryugo, 1996) . MFs give rise to collaterals (Haenggeli et al., 2005; Wright and Ryugo, 1996; Zhou and Shore, 2004) , so it is likely that small bouton terminals arise not only directly from the Sp5 but also as collaterals from MFs.
Sp5 projections to CN convey somatosensory information pertaining to head and neck position and vocal tract gestures to the CN and can modify the output of DCN projection neurons via the MF-granule cell-fusiform cell circuit. This circuit provides information relating to head or neck position to facilitate sound localization (Davis et al., 1996; Kanold and Young, 2001; Young et al., 1995) . It may also act as an "adaptive filter" to cancel out internal noise (such as chewing, self-vocalization, and respiration), as suggested by the observation that stimulation of the trigeminal nerve can suppress the DCN responses elicited by sound (Shore, 2005) . It may serve to improve signal-tonoise ratios when attention is directed to a particular location (Oertel and Young, 2004; Shore, 2005) .
VGLUT1 mediates glutamate transport at ANF terminals
Consistently with previous studies (Brown and Ledwith, 1990; Fekete et al., 1984; Shore and Moore, 1998) , the present study demonstrated that infusion of FG into the labyrinth resulted in heavy labeling of eighth nerve axons and their terminals in the VCNm and DCN3. Large, endbulb-like ANF terminals endings surrounded large somata in VCNm. Small ANF boutons were located in the neuropil of both the VCNm and the DCN3.
The ANF endbulb synapse onto bushy cells provides a secure synaptic connection with the postsynaptic neurons and allows the relay of precise acoustic information. Colocalization of VGLUT1-ir with the FG-labeled AN endings around the somata of large neurons, as well as with small boutons in the neuropil, indicates that VGLUT1 mediates glutamate transport for the bushy cells as well as other cells that receive bouton-type endings on their dendrites, such as stellate or octopus cells (Fekete et al., 1984; Liberman, 1993; Tolbert and Morest, 1982) . Small numbers of FG-labeled ANFs were observed in the shell region. These endings were thin (ϳ1 m), formed small en passant or terminal boutons, and were likely to be type II ANFs (Benson and Brown, 2004; Brown and Ledwith, 1990) . These thin ANFs did not colocalize with either VGLUT1-ir or VGLUT2-ir. This finding is consistent with previous observations that glutaminase-like immunoreactivity is not seen in type II spiral ganglion cells (Altschuler et al., 1984) , suggesting that a neurotransmitter other than glutamate is used by these cells.
Possible roles of VGLUTs in the Sp5 and ANF terminals
The slight structural difference between VGLUT1 and VGLUT2 may lead to different interactions with other proteins and, in turn, affect the vesicle filling and recycling of VGLUT isoforms at the nerve terminal (Fremeau et al., 2004b; Herzog et al., 2001) . The finding that VGLUT1 mediates glutamate transport of the presumed Fig. 6 . Counts of labeled Sp5 terminal endings colocalized with VGLUT1-ir and VGLUT2-ir in different subdivisions of the CN (n ϭ 2). About 50% of MFs and 12% of small Sp5 boutons colabeled with VGLUT2. Significantly fewer (2.5% Ϯ 1%) Sp5 MFs colabeled with VGLUT1 (paired t-test, P Ͻ 0.05), and no small Sp5 boutons colabeled with VGLUT1; 23.6% Ϯ 1% of total Sp5 terminal endings (both MFs and small boutons) colabeled with VGLUT2, which is significantly greater than the endings colabeled with VGLUT1 (2% Ϯ 0.1%; paired t-test, P Ͻ 0.05). In contrast, many labeled ANFs (79.5% Ϯ 7% of endbulb-like terminals and 43.0% Ϯ 3% of bead-like terminals) colocalized with VGLUT1 in the VCNm as well as in the DCN3 (26.0% Ϯ 5%). Neither ANF endbulb-like terminals nor small boutons was colocalized with VGLUT2. Error bars represent SEM. Asterisks indicate significant differences (see text). M, MFs; B, boutons; T, total (MFs and boutons); E, endbulb-like terminals.
type I ANFs in the CN suggests that VGLUT1 is likely involved in conveying the precise temporal information available in the acoustic signal. High temporal precision, for which fast packaging and recycling of glutamate is required, is accomplished by calyceal terminals in several major ascending pathways, including CN and superior olive complex (SOC). Strong VGLUT1 expression in the calyceal terminals in the SOC supports the concept that VGLUT1 is involved in conveying precise timing (Blaesse et al., 2005) . However, it remains unclear whether the VGLUT1 in the presumed parallel fibers in the DCN1 is also associated with fast transmission.
In contrast to the rapid transmission of information between ANFs and magnocellular neurons in the CN, the transfer of information from the somatosensory system to the CN is likely to be either more modulatory or slower in nature. In the cerebellum, MFs are able to adjust synaptic strength via enhanced neurotransmitter release (Sola et al., 2004) . Such a role in synaptic plasticity might also be expected in the DCN, with its cerebellar-like organization (Tzounopoulos et al., 2004) . VGLUT2, which mediates glutamate transport of Sp5 MF endings, might therefore be associated with DCN synaptic plasticity.
The difference in recycling of the two isoforms at the nerve terminals has been previously demonstrated. In the stratum radiatum of the VGLUT1 knockout mouse, repetitive stimulation led to more rapid short-term depression with a slower recovery than in wild-type mice, suggesting that VGLUT2 is responsible for this plasticity. Thus, VGLUT1-and VGLUT2-mediated synapses originating from the same neuron may exhibit different forms of synaptic transmission. Clearly, more physiological evidence is needed to elucidate the functional significance of VGLUT isoforms in synaptic transmission (Fremeau et al., 2004a) .
